Correction: Radiopharmacokinetic modelling and radiation dose assessment of ²²³Ra used for treatment of metastatic castration-resistant prostate cancer (Correction: EJNMMI Phys, (2021), 8, 44, 10.1186/s40658-021-00388-1)

Following publication of the original article [1], the authors reported an error in Table 5. In Table 5 of our paper [1], we incorrectly cited part of the work of Lassmann and Nosske [2] by giving the value of 3.6 mGy/MBq for the liver absorbed dose coefficient due to alphas after intravenous administration of ²²³Ra-chloride. The correct value should be 36 mGy/MBq. Consequently, the following text in page 13 of our paper [1] has to be amended: “The results of the present study were compared to the results of the compartmental modelling of Lassmann and Nosske [20] and were found to be lower (skeletal doses by a factor of 2.3–3.4, colon dose by a factor of 7.2), except for the doses to liver and kidneys, which were found to be higher by a factor of ca. 7.” Amended text: “The results of the present study were compared to the results of the compartmental modelling of Lassmann and Nosske [20] and were found to be lower (skeletal doses by a factor of 2.3–3.4, colon dose by a factor of 7.2), except for the dose to kidneys, which was found to be higher by a factor of ca. 7. The dose coefficient to the liver shows a good agreement with the dose estimated by Lassmann and Nosske [2]”. The authors thank Lassmann and Eberlein for pointing out this error [3] and apologize for the incorrect citation. The original article [1] has been updated.